Vitamin B12: why everything changes after 50
Two active forms, two cellular pathways, one dose calibrated on the only entry door that stays open.
Vitamin B12 holds a unique status in human nutrition: it is the only vitamin whose assimilation depends on a complete gastric and intestinal machinery; hydrochloric acid, pepsin, intrinsic factor, ileal receptor. Each link weakens with the decades, and the same plate then delivers a fraction of what it delivered at thirty. The real question is not the dose but the chemical form: and the entry route that remains open.
- After 50, the active B12 pathway (intrinsic factor) weakens: and it saturates at ~2 µg per intake anyway.
- A passive diffusion route (~1% of the dose) stays open: the rationale for higher oral doses.
- Serum B12 can look «normal» during a real functional deficit: holotranscobalamin, MMA and homocysteine tell the true story.
- base One provides 150 µg in two active forms (hydroxo- + methylcobalamin): cyanocobalamin is excluded.
Why B12 absorption declines with age
Food B12 assimilation follows a four-step cascade, each vulnerable to ageing. In the stomach, food-bound B12 requires acid and pepsin for release; atrophic gastritis (increasingly common after 50) leaves the vitamin locked in its protein matrix (Baik & Russell 1999). Parietal cells produce intrinsic factor, the glycoprotein escorting B12 to the terminal ileum and its cubilin receptor (Nielsen 2012): a system that saturates around 1.5–2 µg per intake. Common pharmacology interferes further: proton-pump inhibitors reduce the acid needed for release (Lam 2013, JAMA), and metformin disturbs the calcium-dependent ileal uptake (Bauman 2000).
The fourth step opens the solution: a passive diffusion route through the intestinal mucosa, independent of intrinsic factor, absorbs about 1% of the ingested dose (Berlin 1968). It stays functional when the active route fails: it simply requires enough B12 in the lumen. That is precisely the reasoning behind a supra-physiological oral dose.
Deficiency signs that mislead
Liver reserves can cover needs for three to five years, so the picture sets in slowly and blends into «ordinary ageing»: persistent fatigue, tingling extremities, working-memory lapses, unstable mood, a smooth sensitive tongue.
One analytical point deserves attention: total serum B12 mostly measures cobalamin bound to haptocorrin; biologically unavailable to tissues. A «normal» result can coexist with a real functional deficit. Three markers read the true status: holotranscobalamin (the active fraction), methylmalonic acid (rises when the mitochondrial pathway lacks cofactor) and homocysteine (rises when methylation slows) (Green 2017).
Cyanocobalamin, hydroxocobalamin, methylcobalamin: which form?
Cyanocobalamin carries a cyanide ligand from industrial purification; every molecule requires cellular decyanation before use. It is the cheapest to produce: base One excludes it. Hydroxocobalamin is the bacterial, food-native form, with superior tissue retention and hepatic reserves (Boddy & Adams 1972): its cyanide affinity even makes it the reference antidote in cyanide poisoning. Methylcobalamin is the active cytoplasmic form; it crosses the blood-brain barrier.
The two cellular pathways of B12
Any cobalamin entering the cell is stripped of its upper ligand and reduced: then two destinations exist (Obeid 2019). The cytoplasmic methylation pathway: methylcobalamin serves methionine synthase, remethylating homocysteine to methionine with 5-MTHF as co-substrate; feeding S-adenosylmethionine, the universal methyl donor for DNA synthesis, neurotransmitters, hepatic phosphatidylcholine and myelin. The mitochondrial energy pathway: adenosylcobalamin serves methylmalonyl-CoA mutase, feeding succinyl-CoA directly into the Krebs cycle.
This is what justifies pairing two forms: hydroxocobalamin's ligand detaches easily, making it a precursor available to both branches on cellular demand, with lasting reserves; methylcobalamin feeds the methylation route by the shortest entry.
B12 and plant-based diets
No plant synthesises B12: only bacteria and archaea do. Spirulina, chlorella and algae mostly contain inactive analogues that occupy transport sites without cofactor activity (Watanabe 2007). Pawlak (2013) documented widespread deficits among vegetarians and vegans across continents.
One formulation point matters: active folate corrects the blood picture of B12 deficiency while letting the neurological damage progress; isolated 5-MTHF can thus mask a cobalamin deficit. base One pairs the two, 350 µg 5-MTHF and 150 µg B12, in the same daily dose: they are co-substrates of the same enzyme.
The base One choice: two active forms, 150 µg
base One delivers 150 µg per 6 g dose as hydroxo- + methylcobalamin. The dose follows the physiology: since the active route saturates near 2 µg, an RDA-level intake depends entirely on a working intrinsic factor; 150 µg mobilises the passive route that stays open under atrophic gastritis, PPIs or long-term metformin. The formula extends the logic: 5-MTHF as co-substrate, B6 (P5P) catalysing transsulfuration toward glutathione with the formula's glycine and glutamine, magnesium as methyltransferase cofactor. The powder format adds one advantage: dissolved B12 meets the entire digestive mucosa already solubilised; extending the surface available for passive diffusion.
Vitamin B12 contributes to normal functioning of the nervous system, to the reduction of tiredness and fatigue, to normal energy-yielding metabolism, to normal red blood cell formation, to normal psychological function and to the normal function of the immune system.
FAQ
Which vitamin B12 at the pharmacy?
Most officinal preparations use cyanocobalamin: stable and cheap. Hydroxo- and methylcobalamin are found in orthomolecular formulations. The reading grid never changes: declared chemical form, and micrograms per dose.
B12 in the morning or evening?
Morning intake suits its role in mitochondrial energy metabolism, together with the whole B-group.
What B12 dose after 50?
The question follows the available absorption route. A status assessed by holotranscobalamin and methylmalonic acid gives the individual answer and may point to dedicated supplementation on top of the daily baseline.
David Giovenco · Micronutrition researcher · Founder & Formulator, nuho
Sources
Berlin 1968, Acta Med Scand · Boddy & Adams 1972, Am J Clin Nutr · Baik & Russell 1999, Annu Rev Nutr · Bauman 2000, Diabetes Care · Watanabe 2007, Exp Biol Med · Nielsen 2012, Nat Rev Gastroenterol Hepatol · Pawlak 2013, Nutr Rev · Lam 2013, JAMA · Green 2017, Nat Rev Dis Primers · Obeid 2019, J Clin Med.